Abbott Molecular Licenses Affy's CGH Microarray Patents

Affymetrix has licensed a number of patents to Abbott Molecular, a division of Abbott Laboratories, Affy said in a statement last week.

The non-exclusive agreement allows Abbott to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.

Affymetrix did not disclose details of the license in the statement and declined to comment on the deal. Representatives of Abbott did not return e-mails or phone calls seeking comment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.